Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands-Reference-Cited by-同舟云学术

Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands

Published:2015-04 Issue:4 Volume:114 Page:646-656
ISSN:0007-0912
Container-title:British Journal of Anaesthesia
language:en
Short-container-title:British Journal of Anaesthesia

Author:

Bird M.F.,Vardanyan R.S.,Hruby V.J.,Calò G.,Guerrini R.,Salvadori S.,Trapella C.,McDonald J.,Rowbotham D.J.,Lambert D.G.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine

Link

http://academic.oup.com/bja/article-pdf/114/4/646/18259502/aeu454.pdf

Reference39 articles.

1. Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile;Dietis;Br J Anaesth,2009

2. Dying from cancer: results of a national population-based investigation;Addington-Hall;Palliat Med,1995

3. Pain medicine: advances in basic sciences and clinical practice;Colvin;Br J Anaesth,2008

4. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice;Abdelhamid;J Pharmacol Exp Ther,1991

5. Trafficking of Preassembled Opioid μ−δ Heterooligomer−Gz Signaling Complexes to the Plasma Membrane: Coregulation by Agonists†;Hasbi;Biochemistry,2007

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical discovery and development of oliceridine (Olinvyk®) for the treatment of post-operative pain;Expert Opinion on Drug Discovery;2022-01-06

2. Evaluation of [Cys(ATTO 488)8]Dermorphin-NH2 as a novel tool for the study of μ-opioid peptide receptors;PLOS ONE;2021-04-23

3. Tuning Down the Pain – An Overview of Allosteric Modulation of Opioid Receptors: Mechanisms of Modulation, Allosteric Sites, Modulator Syntheses;Current Topics in Medicinal Chemistry;2020-12-03

4. Pharmacology of Analgesics;Chronic Pain Management in General and Hospital Practice;2020-07-28

5. Nociceptin/Orphanin FQ (N/OFQ) conjugated to ATTO594: a novel fluorescent probe for the N/OFQ (NOP) receptor;British Journal of Pharmacology;2018-11-06